Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.11 USD | +21.01% | +30.67% | +75.71% |
05-14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
05-14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
481M | - | |||||
49.18B | - | |||||
42.11B | ||||||
40.37B | ||||||
28.85B | ||||||
26.09B |